This section of the Cell Genesys website is for patients seeking enrollment information for Cell Genesys' clinical trials.
GVAX® immunotherapy for Prostate Cancer Phase 3 Trial Currently Open for Enrollment - VITAL-2. This is a Phase 3 trial for patients with Metastatic Hormone-Refractory Prostate Cancer (with cancer-related pain)
